RT @FPoppelaars: Sutimlimab, a blocking mAb against C1s, was approved by the FDA this year for cold agglutinin disease! A new review in @…
812 followers
405 followers
RT @FPoppelaars: Sutimlimab, a blocking mAb against C1s, was approved by the FDA this year for cold agglutinin disease! A new review in @…
558 followers
Sutimlimab, a blocking mAb against C1s, was approved by the FDA this year for cold agglutinin disease! A new review in @FrontImmunol discusses C1s, its role in development & diagnosis of diseases plus the recent progress in drugs targeting C1s: https
20,173 followers
Complement C1s as a diagnostic marker and therapeutic target: Progress and propective: The molecules of the complement system connect the effectors of innate and adaptive immunity and play critical roles in maintaining… #immunology https://t.co/mdKXLWIxOl